SUPREME-DM (Diabetes Mellitis) Treatment Study

NACompletedINTERVENTIONAL
Enrollment

2,378

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions
Diabetes
Interventions
BEHAVIORAL

Intervention Phone Call

The intervention arm consisted of one protocol-structured telephone call from an interventionist who was a nurse health manager (1 site), diabetes educator or diabetes educator trainee (1 site), or pharmacist (2 sites). Interventionists followed the same structured telephone interview protocol to ascertain whether the subject had started taking the new prescription. Those taking the new medication as prescribed received positive reinforcement. Those who either had not filled the prescription or were not taking the medication as directed, were asked about reasons for nonadherence and assisted in identifying and resolving barriers. The median call lasted \< than 5 minutes, and up to 3 call attempts were made. Most intervention calls occurred within 2 to 6 weeks after the prescription date.

Trial Locations (1)

55425

HealthPartners Institute for Education and Research, Minneapolis

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

HealthPartners Institute

OTHER

NCT02192255 - SUPREME-DM (Diabetes Mellitis) Treatment Study | Biotech Hunter | Biotech Hunter